Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients

Transplant Proc. 2001 Nov-Dec;33(7-8):3161-3. doi: 10.1016/s0041-1345(01)02346-6.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Chronic Disease
  • Creatinine / blood
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Drug Resistance
  • Follow-Up Studies
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Retrospective Studies
  • Steroids / adverse effects
  • Steroids / therapeutic use
  • Tacrolimus / therapeutic use*
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Steroids
  • Cyclosporine
  • Creatinine
  • Tacrolimus